![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1321736 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NCK1 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of NCK1 mRNA | CTD | PMID:22206623 | 14-Deoxy-11,12-didehydroandrographolide | increases expression | ISO | RGD:1321736 | 6480464 | 14-deoxy-11, 12-didehydroandrographolide results in increased expression of NCK1 mRNA | CTD | PMID:22101062 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NCK1 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | ISO | RGD:1310688 | 6480464 | 2, 4-dinitrotoluene affects the expression of NCK1 mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | ISO | RGD:1321736 | 6480464 | beta-methylcholine affects the expression of NCK1 mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NCK1 mRNA | CTD | PMID:26251327 | 3,4-methylenedioxymethamphetamine | increases methylation | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of NCK1 promoter | CTD | PMID:26251327 | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of NCK1 mRNA | CTD | PMID:18648102 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1321736 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of NCK1 mRNA | CTD | PMID:12419474 | 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1321736 | 6480464 | Decitabine results in increased expression of NCK1 mRNA | CTD | PMID:20678512 | 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1321736 | 6480464 | [Decitabine co-treated with trichostatin A] results in increased expression of NCK1 mRNA | CTD | PMID:20678512 | all-trans-retinoic acid | decreases expression | ISO | RGD:1321736 | 6480464 | Tretinoin results in decreased expression of NCK1 mRNA | CTD | PMID:15498508 | aristolochic acid | multiple interactions | ISO | RGD:1321736 | 6480464 | aristolochic acid I inhibits the reaction [SLIT2 protein results in increased expression of NCK1 mRNA] more ... | CTD | PMID:30381256 | benzo[a]pyrene | decreases methylation | ISO | RGD:1321736 | 6480464 | Benzoapyrene results in decreased methylation of NCK1 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:1321736 | 6480464 | Benzoapyrene results in increased methylation of NCK1 3' UTR, Benzoapyrene results in increased methylation of NCK1 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1321736 | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | ISO | RGD:1321736 | 6480464 | bisphenol A results in decreased expression of NCK1 mRNA | CTD | PMID:20678512 | bisphenol A | increases expression | ISO | RGD:1310688 | 6480464 | bisphenol A results in increased expression of NCK1 mRNA | CTD | PMID:25181051, PMID:30816183 | cyclosporin A | increases expression | ISO | RGD:1321736 | 6480464 | Cyclosporine results in increased expression of NCK1 mRNA | CTD | PMID:20106945, PMID:25562108 | dicrotophos | decreases expression | ISO | RGD:1321736 | 6480464 | dicrotophos results in decreased expression of NCK1 mRNA | CTD | PMID:28302478 | Diisodecyl phthalate | increases expression | EXP | | 6480464 | diisodecyl phthalate results in increased expression of NCK1 mRNA | CTD | PMID:25270620 | ethanol | multiple interactions | ISO | RGD:1321736 | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NCK1 mRNA | CTD | PMID:29432896 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of NCK1 mRNA | CTD | PMID:25629700 | folpet | decreases expression | EXP | | 6480464 | folpet results in decreased expression of NCK1 mRNA | CTD | PMID:31558096 | gentamycin | increases expression | ISO | RGD:1310688 | 6480464 | Gentamicins results in increased expression of NCK1 mRNA | CTD | PMID:22061828 | irinotecan | decreases expression | ISO | RGD:1321736 | 6480464 | Irinotecan metabolite results in decreased expression of NCK1 mRNA, Irinotecan results in decreased expression of NCK1 mRNA | CTD | PMID:15956246 | methotrexate | decreases expression | ISO | RGD:1321736 | 6480464 | Methotrexate results in decreased expression of NCK1 mRNA | CTD | PMID:17400583 | methoxychlor | increases methylation | ISO | RGD:1310688 | 6480464 | Methoxychlor results in increased methylation of NCK1 gene | CTD | PMID:23303685 | methyl methanesulfonate | decreases expression | ISO | RGD:1321736 | 6480464 | Methyl Methanesulfonate results in decreased expression of NCK1 mRNA | CTD | PMID:23649840 | methylmercury chloride | decreases expression | ISO | RGD:1321736 | 6480464 | methylmercuric chloride results in decreased expression of NCK1 mRNA | CTD | PMID:28001369 | phenobarbital | affects expression | ISO | RGD:1321736 | 6480464 | Phenobarbital affects the expression of NCK1 mRNA | CTD | PMID:19159669 | phenylmercury acetate | decreases expression | ISO | RGD:1321736 | 6480464 | Phenylmercuric Acetate results in decreased expression of NCK1 mRNA | CTD | PMID:26272509 | piroxicam | decreases expression | ISO | RGD:1321736 | 6480464 | Piroxicam results in decreased expression of NCK1 mRNA | CTD | PMID:21858171 | potassium chromate | decreases expression | ISO | RGD:1321736 | 6480464 | potassium chromateVI results in decreased expression of NCK1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RGD:1321736 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NCK1 mRNA | CTD | PMID:22079256 | progesterone | increases expression | ISO | RGD:1310688 | 6480464 | Progesterone results in increased expression of NCK1 mRNA | CTD | PMID:21770760 | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of NCK1 mRNA | CTD | PMID:21278054 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of NCK1 mRNA | CTD | PMID:23221170 | sodium arsenate | increases expression | EXP | | 6480464 | sodium arsenate results in increased expression of NCK1 mRNA | CTD | PMID:30953684 | sodium arsenite | increases expression | ISO | RGD:1321736 | 6480464 | sodium arsenite results in increased expression of NCK1 mRNA | CTD | PMID:12016162 | tamibarotene | affects expression | ISO | RGD:1321736 | 6480464 | tamibarotene affects the expression of NCK1 mRNA | CTD | PMID:15498508 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of NCK1 mRNA | CTD | PMID:31919559 | trichostatin A | multiple interactions | ISO | RGD:1321736 | 6480464 | [decitabine co-treated with trichostatin A] results in increased expression of NCK1 mRNA | CTD | PMID:20678512 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of NCK1 mRNA | CTD | PMID:28973697 | valproic acid | decreases expression | ISO | RGD:1321736 | 6480464 | Valproic Acid results in decreased expression of NCK1 mRNA | CTD | PMID:26272509, PMID:29154799 | zoledronic acid | increases expression | ISO | RGD:1321736 | 6480464 | zoledronic acid results in increased expression of NCK1 mRNA | CTD | PMID:24714768 | |